文献速递主动脉疾病

应用新型覆膜球囊扩张支架血管内治疗主动脉缩窄

Endovascular Management of Aortic Coarctation Using Innovative Stent Technology.
PubMed 文献 · Ann Vasc Surg · 2026-08-27

BACKGROUND: Aortic coarctation (AC) is a congenital defect characterized by narrowing of the aorta usually near the left subclavian artery.…

要点

  • 覆膜球囊扩张支架治疗成人主动脉缩窄技术成功率高
  • 术后压力阶差显著改善且无不良事件
  • 中期随访无复发,支持该技术安全有效

核心结论

  • 中期数据支持覆膜球囊扩张支架是治疗主动脉缩窄安全有效的选择。

研究设计与样本

  • 单中心回顾性研究,连续纳入11例接受Cheatham-Platinum支架治疗的成人主动脉缩窄患者。

主要发现

  • 病变平均长度5.4±1.8 mm,平均主动脉直径7.6±1.2 mm,位于左锁骨下动脉远端26.1±4.0 mm。
  • 除2例外所有患者血压控制改善,无不良事件,中位住院1天,平均随访25.3±7.55个月无复发。

临床怎么用

  • 对于成人主动脉缩窄,可考虑使用覆膜球囊扩张支架行血管内治疗。

局限性

  • 单中心、回顾性、样本量小(11例),随访时间中等。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aortic coarctation (AC) is a congenital defect characterized by narrowing of the aorta usually near the left subclavian artery. Repair has traditionally been performed via an open approach, but off-label endovascular options have emerged for the treatment of patients diagnosed in adolescence or adulthood. Complications related to percutaneous ballooning and stenting such as aortic dissection, rupture, and embolization have been recognized. The gap in existing technology has led to the development of a covered balloon-expandable stent with balloon-in-balloon technology with a specific indication for treatment of AC. METHODS: This report is a single-center, retrospective review of 11 adult patients consecutively treated with a Cheatham-Platinum stent. Primary indications for intervention were hypertension, pseudoaneurysm, aortic insufficiency, and claudication. Five patients had prior aortic intervention (3 open-repair and 2 off-label aortic endografts). Rapid ventricular pacing was used for all deployments. RESULTS: The treated lesions, with a mean length of 5.4 ± 1.8 mm and a mean aortic diameter of 7.6 ± 1.2 mm, were located 26.1 ± 4.0 mm distal to the left subclavian artery. Technical success was reported in all 11 patients with improvement of pressure gradient from 33.6 ± 9.1 mm Hg before the procedure to <5 mm Hg in all cases. All but 2 patients experienced improved blood pressure control. No adverse events were reported. The median length of stay was 1 day. Mean follow-up duration was 25.3 ± 7.55 months with no recurrences. CONCLUSION: These midterm data are supportive of the use of covered balloon-expandable stents with the balloon-in-balloon technology as a safe and effective treatment option for AC. Expanded indications of this device are likely feasible.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Foster P, Cornelius M, Crittendon I, et al. Endovascular Management of Aortic Coarctation Using Innovative Stent Technology. Ann Vasc Surg. 2026. PMID: 42648468. doi:10.1016/j.avsg.2026.08.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。